Last update 30 Jul 2025

Novel erythropoiesis stimulant (Shengji Pharma)

Overview

Basic Info

Drug Type
Colony-stimulating factors
Synonyms
SJ-01, SJ01
Target
EPO receptor
Action
agonists, stimulants
Mechanism
EPO receptor agonists(Erythropoietin receptor agonists), Erythropoiesis stimulants(Erythropoiesis stimulants)
Therapeutic Areas
Hemic and Lymphatic DiseasesUrogenital Diseases
Active Indication-
Inactive Indication
AnemiaAnemia of renal diseasechronic renal failure anemia
Originator Organization
Suzhou Shengji Pharmaceutical Co LtdSuzhou Shengji Pharmaceutical Co Ltd
Active Organization-
Inactive Organization
Shanghai Qiangbang Biological Technology Co., Ltd.
Shanghai Bao Pharmaceutical Co. Ltd.Shanghai Bao Pharmaceutical Co. Ltd.Suzhou Shengji Pharmaceutical Co LtdSuzhou Shengji Pharmaceutical Co Ltd
+ [1]
License Organization-
Drug Highest PhaseDiscontinuedPhase 3
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with Novel erythropoiesis stimulant (Shengji Pharma)
CTR20180129
/ CompletedNot Applicable
皮下注射长效人红细胞生长刺激素注射液治疗慢性透析肾性贫血的安全性、药代动力学及初步药效的临床研究
[Translation] Clinical study on the safety, pharmacokinetics and preliminary efficacy of subcutaneous long-acting human erythrocyte growth stimulating hormone injection in the treatment of chronic dialysis renal anemia
JPRN-jRCT1090220102
/ SuspendedNot ApplicableIIT
The examination of comparison about the pain relief at the time of a hypodermic injection of erythropoiesis stimulating agent.
100 Clinical Results associated with Novel erythropoiesis stimulant (Shengji Pharma)
Login to view more data
100 Translational Medicine associated with Novel erythropoiesis stimulant (Shengji Pharma)
Login to view more data
100 Patents (Medical) associated with Novel erythropoiesis stimulant (Shengji Pharma)
Login to view more data
100 Deals associated with Novel erythropoiesis stimulant (Shengji Pharma)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
AnemiaPhase 3
China
Shanghai Bao Pharmaceutical Co. Ltd.Shanghai Bao Pharmaceutical Co. Ltd.
30 Jan 2022
chronic renal failure anemiaClinical
China
Suzhou Shengji Pharmaceutical Co LtdSuzhou Shengji Pharmaceutical Co Ltd
30 Jan 2022
Anemia of renal diseaseClinical
China
Shanghai Qiangbang Biological Technology Co., Ltd.
03 Jan 2018
Anemia of renal diseaseClinical
China
Suzhou Kangju BIOTECHNOLOGY Co., Ltd.Suzhou Kangju BIOTECHNOLOGY Co., Ltd.
03 Jan 2018
Anemia of renal diseaseClinical
China
Suzhou Shengji Pharmaceutical Co LtdSuzhou Shengji Pharmaceutical Co Ltd
03 Jan 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free